Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China flag China · Delayed Price · Currency is CNY
8.22
-0.12 (-1.44%)
Sep 24, 2026, 3:00 PM CST

SHA:600420 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
545.12941.61,084691.88627.79568.28
Depreciation & Amortization
722.19710.1772.32818.89842.49820.27
Other Amortization
13.9813.435.986.366.0610.48
Loss (Gain) From Sale of Assets
3.142.6531.3131.851.1-0.2
Asset Writedown & Restructuring Costs
33.3632.7928.2613.133.43135.66
Loss (Gain) From Sale of Investments
-141.67-133.9-64.11-27.45-2.3424.04
Provision & Write-off of Bad Debts
8.4315.67-2.36-18.05-17.5924.87
Other Operating Activities
265.12297.41427.46399.15393.7405.67
Change in Accounts Receivable
137.87187.08732.85485.43463.12-921.35
Change in Inventory
234.69485.7160.54163.27625.24195.31
Change in Accounts Payable
-740.35-833.49-918.52-832.62-30.39444.18
Operating Cash Flow
1,0781,6982,2561,7202,8561,680
Operating Cash Flow Growth
-2.58%-24.73%31.13%-39.76%70.01%7.66%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-233.2-263.83-219.77-357.19-307.44-521.44
Sale of Property, Plant & Equipment
5.356.1521.9510.9653.72
Divestitures
102.6102.6----
Investment in Securities
839.723.0332.01-1.14
Other Investing Activities
-2,220-2,240-661.4-1,019-8.31
Investing Cash Flow
-1,506-2,392-856.23-1,363-302.44-508.28

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--50452,3463,685
Total Debt Issued
--50452,3463,685
Long-Term Debt Repaid
--1,060-61.44-774.23-3,203-3,402
Lease Payments
-9.55-10.3-16.44-13.99-16.39-
Total Debt Repaid
-39.55-1,060-61.44-774.23-3,203-3,402
Net Debt Issued (Repaid)
-39.55-1,060-11.44-729.23-856.83282.87
Issuance of Common Stock
----1,188-
Common Dividends Paid
-680.55-427.9-300.68-189.35-184.7-212.46
Other Financing Activities
-10.39-154.25-103.3-174.8-581.78-732.81
Financing Cash Flow
-730.48-1,642-415.42-1,093-435.32-662.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-18.8915.3429.6332.0794.24-40.08
Net Cash Flow
-1,177-2,3211,014-703.832,212468.9

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
845.191,4342,0361,3632,5481,158
Free Cash Flow Growth
-1.46%-29.56%49.37%-46.50%120.01%-2.03%
Free Cash Flow Margin
10.03%15.32%18.62%11.29%19.66%8.31%
Free Cash Flow Per Share
0.631.071.521.072.200.98
Levered Free Cash Flow
197.96873.691,6791,8061,634621.88
Unlevered Free Cash Flow
199.57876.431,7021,8421,701690.92
Free Cash Flow After Leases
835.641,4242,0201,3492,5321,158

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
498.98608.01693.04751.63617.65696.29
Change in Working Capital
-371.29-181.65-26.52-195.371,001-309.41